Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

BACKGROUND: The safety and immunogenicity of live respiratory syncytial virus (RSV) candidate vaccine, LID/ΔM2-2/1030s, with deletion of RSV ribonucleic acid synthesis regulatory protein M2-2 and genetically stabilized temperature-sensitivity mutation 1030s in the RSV polymerase protein was evaluate...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Infect Dis
Κύριοι συγγραφείς: McFarland, Elizabeth J, Karron, Ruth A, Muresan, Petronella, Cunningham, Coleen K, Libous, Jennifer, Perlowski, Charlotte, Thumar, Bhagvanji, Gnanashanmugam, Devasena, Moye, Jack, Schappell, Elizabeth, Barr, Emily, Rexroad, Vivian, Fearn, Laura, Spector, Stephen A, Aziz, Mariam, Cielo, Mikhaela, Beneri, Christy, Wiznia, Andrew, Luongo, Cindy, Collins, Peter, Buchholz, Ursula J
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Oxford University Press 2020
Θέματα:
Major Articles and Brief Reports
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6996856/
https://ncbi.nlm.nih.gov/pubmed/31758177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz603
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια